Dr. Nora E. Wessendorf, LL.M. (Washington)

Düsseldorf Allemagne

Prix à l'honneur

Legal 500 2026

Recommended Lawyer for Patent Litigation

Nora Wessendorf is a patent litigator specialising in forensic advice of international and national corporations in patent infringement proceedings. As a member of the Patents Technology & Life Sciences practice area, she advises clients in the fields of automotive and mechanical engineering, telecommunications, electronics, medical technology, digital health applications as well as pharmaceuticals and chemistry.

She also advises clients on product launches and transactional matters, in particular licensing agreements, R&D agreements and in the context of corporate transactions. As a member of the New York State Bar Association, Nora Wessendorf is also familiar with the concerns of US-based clients involved in German litigation.

CV

Since 2021 Salary Partner, Taylor Wessing

2019 – 2021 Senior Associate, Taylor Wessing

2016 – 2019 Associate, Taylor Wessing

Carrière

Since 2021 Salary Partner, Taylor Wessing

2019 – 2021 Senior Associate, Taylor Wessing

2016 – 2019 Associate, Taylor Wessing

Formation

2019 Admitted to the New York State Bar

2016 LL.M. (Intellectual Property Law), George Washington University Law School, Washington, D.C.

2016 Dr. iur., Westfalian Wilhelms University Münster

Publications

Eckpunkte einer IP-Strategie für Deutschland, in: Bundesverband der Deutschen Industrie e.V., with Stephan Manuel Nagel and Niklas Melzer

The America Invents Act’s impact on patent law harmonization in Germany and the US, June 2016 (dissertation)

Know-how protection for technical inventions in the US. GRUR-Int 2013, p. 876

Groupes & Associations

GRUR
AIPPI
New York State Bar Association
WIN: Women in Intellectual Property Network

Langues étrangères

Prix et distinctions

Legal 500 2026

Featured

Legal 500 2025

JUVE Awards 2023

Legal 500 Germany 2024

Actualités et publications récentes

View Nora E.'s insights

Cliquer ici pour en savoir plus

UPC

New Court, new approaches: How the UPC is reshaping pharmaceutical patent litigation

11 mai 2026

par plusieurs auteurs

Brevets et innovation

Game over for the divisional game?

18 décembre 2024

Briefing

par Dr. Nora E. Wessendorf, LL.M. (Washington)

Cliquer ici pour en savoir plus

Brevets et innovation

JUVE Awards 2023: Taylor Wessing named "Law Firm of the Year for IP”

27 octobre 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus

Dr. Nora E. Wessendorf, LL.M. (Washington)

Legal 500 2026

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Publications

Groupes & Associations

Langues étrangères

Prix et distinctions

Legal 500 2026

Legal 500 2025

JUVE Awards 2023

Legal 500 Germany 2024

Actualités et publications récentes

New Court, new approaches: How the UPC is reshaping pharmaceutical patent litigation

Dr. Nora E. Wessendorf, LL.M. (Washington)

Legal 500 2026

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Publications

Groupes & Associations

Langues étrangères

Prix et distinctions

Legal 500 2026

Legal 500 2025

JUVE Awards 2023

Legal 500 Germany 2024

Actualités et publications récentes

New Court, new approaches: How the UPC is reshaping pharmaceutical patent litigation

Related news & insights

Open Source in Healthcare and Life Sciences – Legal Framework and Compliance Requirements

The UPC’s first referral to the European Court of Justice: Cross-border preliminary injunctions against intermediaries and non-UPC defendants

Taylor Wessing advises co-lead investor East X Ventures on Proxima Fusion's € 411 million Series A-2 financing round

Hungarian supreme court on legal standing to challenge generic marketing authorisations

Case law – VfGH on the eImpfpass and central vaccination register

The new Product Liability Directive: three life sciences priorities before the 2026 deadline

Update: AI-Enabled Medical Devices and IVDs Confirmed as “High-Risk”

Poland’s new AI systems act: a regulator and practical tools

Medical Cannabis Platforms Breach Advertising Ban

France renews its simplified anti-gift conventions – what life sciences companies operating in France need to know

Autres avocats qui pourraient vous intéresser

Rendez-vous à